The largest database of trusted experimental protocols

7 protocols using premix wst 1 reagent

1

Anticancer Drug Cytotoxicity Evaluation

Check if the same lab product or an alternative is used in the 5 most similar protocols
To evaluate the effect of anticancer drugs, 1 × 104 cells were seeded into 96‐well culture plates and incubated for 24 h at 37°C with 5% CO2. We subsequently added cisplatin (Sigma‐Aldrich, St. Louis, MO, USA) (0, 25, 50, 100, 200 or 400 μM) or carboplatin (Sigma‐Aldrich) (0, 31.25, 62.5, 125, 250 or 500 μM). After 72 h (cisplatin) or 48 h (carboplatin) of incubation, 10 μL of Premix WST‐1 reagent (Takara Bio, Kyoto, Japan) were added to each well. After 1 h incubation, absorbance was measured. The absorbance at 450 nm was subtracted from the background absorbance (690 nm).
+ Open protocol
+ Expand
2

Transduction of Cells with AAV2

Check if the same lab product or an alternative is used in the 5 most similar protocols
The cells were seeded in 96-well plates at 1×103 cells per well. After 12 h, the cells were transduced with AAV2-shE6E7 at 0–1×107 vg/cell or AAV2-shNC at 1×105 vg/cell. After 72 h, 10 μl premix WsT-1 reagent (Takara Bio, Otsu, Japan) was added, and the absorbance at 450 nm was measured using a SpectraMax 190 microplate reader (Molecular Devices, Sunnyvale, CA, USA) after 1 h.
+ Open protocol
+ Expand
3

Cytochrome P450 Reporter Assay in HepG2 Cells

Check if the same lab product or an alternative is used in the 5 most similar protocols
ELuc-HepG2 or CYPs-ELuc-HepG2 cells were seeded in 96-well black clear bottom plates (Nunc, Wiesbaden, Germany) at a density of 1 × 104 cells per well. After an overnight incubation, the medium was replaced with DMEM without phenol red (Gibco-BRL) but with 10% FBS (HyClone Laboratories), 4 mM glutamine, non-essential amino acids (Gibco-BRL), 1 mM pyruvate (FUJIFILM Wako Pure Chemical Corporation), 25 mM HEPES/NaOH (pH 7.0, Sigma–Aldrich), and 300 μM D-luciferin potassium salt (Resem B.V., Lijnden, The Netherlands) with or without compound. After incubation for 3 days in a CO2 incubator, ELuc luminescence intensity in the cells was measured. The 96-well plate was set in a microplate-type luminometer (AB-2350 Phelios; ATTO, Tokyo, Japan) and luminescence was measured without disrupting the cells for 5 s. For the WST-1 assay, Premix WST-1 reagent (Takara Bio Inc., Shiga, Japan) was added to the remaining HepG2 cells and incubation was carried out for 1 to 2 h at 37 °C. Absorbance was measured at 450 nm (reference 620 nm) using the microplate reader Infinite 200 PRO (Tecan).
+ Open protocol
+ Expand
4

Evaluating Epigenetic Drug Toxicity in 2D Tumor Cells and Organoids

Check if the same lab product or an alternative is used in the 5 most similar protocols
For 2D tumour cell culture, tumour cells were seeded into 96 well plates at 2,000 cells per well and cultured for 72 h. For tumour organoids, tumour organoids with diameter between 70 and 150 μm were seeded at 50 organoids per well into 96-well microplates with ultra-low attachment surface (Corning). Cells or tumour organoids were treated with indicated compound at the final concentration of 1μM. After 3-day culture, tumour organoids were dissociated into single cells using TrypLE Express (Corning) at 37°C with a shaking velocity of 500 rpm on a thermomixer (Eppendorf) for 15 min. The 96-well microplates were added with 10 μl/well of Premix WST-1 reagent (TaKaRa) and incubated for 1 h. The microplates were read at absorbance of 450 nm on the Epoch microreader (BioTek). The toxicity of the epigenetic drugs was quantified using the Premix WST-1 reagent according to the manufacturer’s protocol.
+ Open protocol
+ Expand
5

Neuro2a Cell Viability Assay

Check if the same lab product or an alternative is used in the 5 most similar protocols
Neuro2a cells were cultured in complete medium for 24 h under an atmosphere of 5% CO2/air at 37 °C. Cells were transfected with the LNPs. It was then replaced with complete medium and incubated for 1 h under an atmosphere of 5% CO2/air at 37 °C. The medium was replaced with complete medium containing PremixWST-1 reagent (TAKARA Bio Inc., Shiga, Japan) and incubated for 2 h under an atmosphere of 5% CO2/air at 37 °C. Absorbance was detected at 440 and 650 nm using a microplate reader. Relative cell viability was calculated by normalizing the cell viability of the control.

where Vt and Vu represent the cell viability for treated and untreated cells with samples, respectively.
+ Open protocol
+ Expand
6

Thermal Shift Assay for THP-1 Cells

Check if the same lab product or an alternative is used in the 5 most similar protocols
GTx1-15 was obtained from Alomone Labs (Jerusalem, Israel). Human plasma was purchased from KOJIN BIO (Saitama, Japan). The protein thermal shift starter kit was from Thermo Fisher Scientific (Tokyo, Japan). RPMI-1640 with L-glutamine and phenol red, sodium hydrogen carbonate, and Tris-HCl were purchased from Wako Chemicals (Osaka, Japan). A human monocytic leukemia cell line, THP-1 (No. JCRB0112), was from the Japanese Collection of Research Bioresources Cell Bank (Osaka, Japan). Penicillin-streptomycin solution was obtained from Life Technologies Japan Ltd. (Tokyo, Japan). HyClone fetal bovine serum was purchased from GE Healthcare Japan (Tokyo, Japan). Premix WST-1 reagent was purchased from Takara Bio (Shiga, Japan).
+ Open protocol
+ Expand
7

Evaluating Epigenetic Drug Toxicity in 2D Tumor Cells and Organoids

Check if the same lab product or an alternative is used in the 5 most similar protocols
For 2D tumour cell culture, tumour cells were seeded into 96 well plates at 2,000 cells per well and cultured for 72 h. For tumour organoids, tumour organoids with diameter between 70 and 150 μm were seeded at 50 organoids per well into 96-well microplates with ultra-low attachment surface (Corning). Cells or tumour organoids were treated with indicated compound at the final concentration of 1μM. After 3-day culture, tumour organoids were dissociated into single cells using TrypLE Express (Corning) at 37°C with a shaking velocity of 500 rpm on a thermomixer (Eppendorf) for 15 min. The 96-well microplates were added with 10 μl/well of Premix WST-1 reagent (TaKaRa) and incubated for 1 h. The microplates were read at absorbance of 450 nm on the Epoch microreader (BioTek). The toxicity of the epigenetic drugs was quantified using the Premix WST-1 reagent according to the manufacturer’s protocol.
+ Open protocol
+ Expand

About PubCompare

Our mission is to provide scientists with the largest repository of trustworthy protocols and intelligent analytical tools, thereby offering them extensive information to design robust protocols aimed at minimizing the risk of failures.

We believe that the most crucial aspect is to grant scientists access to a wide range of reliable sources and new useful tools that surpass human capabilities.

However, we trust in allowing scientists to determine how to construct their own protocols based on this information, as they are the experts in their field.

Ready to get started?

Sign up for free.
Registration takes 20 seconds.
Available from any computer
No download required

Sign up now

Revolutionizing how scientists
search and build protocols!